Sarah Lund Peterson, PA
Medical · Plymouth, MNNPI 1598942823
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 73 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 8.3% — the pattern of someone who eats at a lot of different presentations.
Across 73 payments — averaging $16.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$100
- Sun Pharmaceutical Industries Inc.$87
- Incyte Corporation$86
- Regeneron Healthcare Solutions, Inc.$82
- Sanofi$80
- Johnson & Johnson$75
- plus $686 from 20 others
What the payments were for
- Food & beverage$1,195100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 7 | $100 |
| Sun Pharmaceutical Industries Inc. | 5 | $87 |
| Incyte Corporation | 5 | $86 |
| Regeneron Healthcare Solutions, Inc. | 4 | $82 |
| Sanofi | 5 | $80 |
| Johnson & Johnson | 5 | $75 |
| Arcutis Biotherapeutics, Inc. | 4 | $69 |
| E.r. Squibb & Sons, L.L.C. | 4 | $66 |
| UCB, Inc. | 3 | $59 |
| Galderma Laboratories, L.p. | 4 | $59 |
| Helsinn Therapeutics (U.S.), Inc. | 3 | $52 |
| AbbVie | 3 | $50 |
| Lilly USA, LLC | 3 | $40 |
| Boehringer Ingelheim | 2 | $37 |
| Verrica Pharmaceuticals Inc. | 2 | $37 |
| Blueprint Medicines Corporation | 1 | $34 |
| Kyowa Kirin, Inc. | 2 | $32 |
| Fresenius Kabi USA, LLC | 1 | $28 |
| LEO Pharma Inc. | 2 | $26 |
| Biofrontera Inc. | 2 | $26 |
| Mylan Institutional Inc. | 1 | $17 |
| Dermavant Sciences, Inc. | 1 | $14 |
| Pfizer | 1 | $13 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $12 |
| Novartis | 1 | $11 |
| Organon | 1 | $5 |
How this compares
$1,195 in reported general payments places this provider in the 85th percentile of 202 medical providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 14 | $50,717 |
| Clobetasol Propionate | 100 | $2,357 |
| Calcipotriene | 12 | $1,678 |
| Ketoconazole | 85 | $1,631 |
| Fluocinonide | 15 | $1,306 |
| Triamcinolone Acetonide | 106 | $1,187 |
| Metronidazole | 19 | $989 |
| Minoxidil | 34 | $588 |
| Doxycycline Monohydrate | 13 | $279 |
| Hydrocortisone | 54 | $250 |
| MethotrexateMethotrexate Sodium | 17 | $241 |
| Ciclopirox | 14 | $209 |
| Spironolactone | 12 | $207 |
| Mupirocin | 23 | $164 |
| Cephalexin | 13 | $136 |
Paid to pharmacies, not to this prescriber.
Other medical in Plymouth
- Rachel StevensPlymouth$820
- Kristina ThissenRogers$178K
- Cynthia KonrathMinnetonka$95K
- Tyler JohnsonWaconia$28K
- Eliza AbrahamWhite Bear Lake$19K
- Tobie MeyerMaple Grove$13K
- Emily BurkmanWhite Bear Lake$6K
- Sarah SeilerMaple Grove$4K
- Kerry GuntliEden Prairie$3K
- Katie PetersonMaple Grove$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.